Why is Lyka Labs falling/rising?

As of 18-Sep, Lyka Labs Ltd is currently priced at 100.00, showing no change (0.00%) in its stock price. The stock has underperformed its sector today by 1.05%, and its delivery volume has significantly decreased by 64.66% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 0.25%, and it has also shown negative returns of 36.97% year-to-date and 33.86% over the past year. Despite these declines, the company has demonstrated high management efficiency with a return on capital employed (ROCE) of 17.59% and has reported positive results for the last five consecutive quarters, with a remarkable growth in profit after tax (PAT) of 502.99% in the latest six months.
In the broader market context, the Sensex has increased by 1.80% over the past week, contrasting with Lyka Labs' decline, which highlights the stock's underperformance relative to the benchmark. The company has a high debt-to-equity ratio of 2.75, contributing to concerns about its long-term viability despite its healthy operating profit growth. While the stock is trading at a discount compared to its peers and has shown significant profit growth, the overall negative sentiment surrounding its performance in both the near and long term, combined with high debt levels, suggests that investors may be cautious, leading to the stock's current stagnation.